Clinical Trial Update: Study of SPG601 in Adult Men With Fragile X Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 study of SPG601 in adult men with Fragile X Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fragile Syndrome

Drugs mentioned

• SPG601 (SPG601)

Snippet

Sponsor: Spinogenix | Conditions: Fragile X Syndrome | Phase 2 | Status: COMPLETED